nifekalant hydrochloride has been researched along with Acidosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ando, K; Kazusa, K; Nakamura, Y; Sugiyama, A; Watanabe, Y | 1 |
Amino, M; Deguchi, Y; Ikari, Y; Inokuchi, S; Kodama, I; Matsuzaki, A; Morita, S; Nakagawa, Y; Sugimoto, A; Tanabe, T; Usui, K; Yamamoto, I; Yoshioka, K | 1 |
1 trial(s) available for nifekalant hydrochloride and Acidosis
Article | Year |
---|---|
Can nifekalant hydrochloride be used as a first-line drug for cardiopulmonary arrest (CPA)? : comparative study of out-of-hospital CPA with acidosis and in-hospital CPA without acidosis.
Topics: Acidosis; Aged; Anti-Arrhythmia Agents; Electric Countershock; Epinephrine; Female; Heart Arrest; Humans; Hydrogen-Ion Concentration; Inpatients; Male; Middle Aged; Outpatients; Potassium; Pyrimidinones; Resuscitation; Retrospective Studies; Tachycardia, Ventricular | 2006 |
1 other study(ies) available for nifekalant hydrochloride and Acidosis
Article | Year |
---|---|
Effects of pH on nifekalant-induced electrophysiological change assessed in the Langendorff heart model of guinea pigs.
Topics: Acidosis; Action Potentials; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Electrocardiography; Guinea Pigs; Humans; Hydrogen-Ion Concentration; Male; Perfusion; Pyrimidinones; Time Factors; Torsades de Pointes | 2014 |